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Abstract
Zaire ebolavirus (ZEBOV) infections are associated with high lethality in primates. ZEBOV primarily targets mononuclear
phagocytes, which are activated upon infection and secrete mediators believed to trigger initial stages of pathogenesis. The
characterization of the responses of target cells to ZEBOV infection may therefore not only further understanding of
pathogenesis but also suggest possible points of therapeutic intervention. Gene expression profiles of primary human
macrophages exposed to ZEBOV were determined using DNA microarrays and quantitative PCR to gain insight into the
cellular response immediately after cell entry. Significant changes in mRNA concentrations encoding for 88 cellular proteins
were observed. Most of these proteins have not yet been implicated in ZEBOV infection. Some, however, are inflammatory
mediators known to be elevated during the acute phase of disease in the blood of ZEBOV-infected humans. Interestingly,
the cellular response occurred within the first hour of Ebola virion exposure, i.e. prior to virus gene expression. This
observation supports the hypothesis that virion binding or entry mediated by the spike glycoprotein (GP1,2) is the primary
stimulus for an initial response. Indeed, ZEBOV virions, LPS, and virus-like particles consisting of only the ZEBOV matrix
protein VP40 and GP1,2 (VLPVP40-GP) triggered comparable responses in macrophages, including pro-inflammatory and pro-
apoptotic signals. In contrast, VLPVP40 (particles lacking GP1,2) caused an aberrant response. This suggests that GP1,2 binding
to macrophages plays an important role in the immediate cellular response.
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Introduction
Zaire ebolavirus (ZEBOV) is a member of the family Filoviridae
within the order Mononegavirales [1]. It was discovered in 1976 in
what is now the Democratic Republic of the Congo [2] as the
etiological agent of a severe human viral hemorrhagic fever known
as Ebola Hemorrhagic Fever (EHF). Infection with ZEBOV
typically results in a rapidly fatal illness associated with high-level
viremia, lack of an effective immune response, drastic lymphope-
nia, a severe coagulation disorder including disseminated intra-
vascular coagulation and limited hemorrhages, widespread focal
tissue necroses, systemic shock and multiorgan failure (reviewed in
detail in [3]). While the pathogenesis of ZEBOV infection has
been relatively well described in experimental animals [4,5], only a
few studies were reported that shed light on the molecular events
following infection in humans. Unfortunately, these studies are
partially contradictory. For instance, higher serum cytokine
concentrations (IFN-a, IFN-c, IL-2, IL-6, and TNF-a) were
measured in seven fatally infected patients compared to two
survivors in one study, suggesting that a hyperactive immune
responses may contribute to fatal outcome [6]. Other studies,
describing the responses of eight fatally infected patients and four
survivors, did not reveal significant concentration differences of
IFN-a, IL-2, and TNF-a. On the other hand, that study suggested
that fatal infections are due to generalized immunosuppression,
including decreased IFN-c, IL-2, and IL-4 concentrations,
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The largest study to date included 42 fatally infected patients and
14 survivors. Hypersecretion of proinflammatory cytokines,
chemokines and growth factors (IL-1b, IL-1RA, IL-6, IL-8, IL-
15, IL-16, CXCL1 (GROa), CXCL10 (IP-10), eotaxin, M-CSF,
MIP-1a, MIP-1b, MCP-1, MIF) and decreased concentrations of
T lymphocyte-derived cytokines (IL-2, IL-3, IL-4, IL-5, IL-9, IL-
13) concomitant to apoptotic loss of CD4 and CD8 T lymphocytes
were typical for fatal cases [11]. Unfortunately, all these data
reveal only the extent of homeostatic disarray in ZEBOV-infected
individuals, but not its origin or genesis. It is therefore important to
measure the responses of individual human cell types to infection,
ideally in chronological order of their infection in vivo. Mononu-
clear phagocytes are very early, if not initial, targets of ZEBOV in
humans and experimentally infected animals [12,13,14,15]. In
vitro, human and nonhuman primate macrophages are highly
susceptible to ZEBOV infection with subsequent robust virus
production [16,17], suggesting they may be the major source of
the high viremia observed during the critical stages of infection.
Studies performed in vitro are also strongly indicative that
macrophages play a major role in inducing cytokine/chemokine
dysregulation. For instance, human monocytes and macrophages
infected with ZEBOV react with increased expression of MCP-1,
CXCL1, IL-1b, IL-6, IL-8, MIP-1a, RANTES and TNF-a
[16,18]. Previous studies revealed that similar increased levels of
expression of some of these cytokines were triggered by incubation
of human macrophages with Ebola virus-like particles (VLPs)
consisting of the ZEBOV matrix protein VP40 and the spike
glycoprotein (GP1,2) [19] or with UV-inactivated ZEBOV [16].
These findings indicated that virus replication might not be
required for the activation of macrophages.
The aim of the current study was to determine the gene
expression profiles of human macrophages exposed to infectious
Ebola virions using DNA microarray technology (reviewed in
[20,21,22,23,24]) and therefore elucidate virus-host interactions.
Here, we determine the initial responses of human macrophages to
Ebola virion exposure. In a first set of experiments, DNA
microarray analysis was performed to determine gene expression
profiles of human macrophages 1 h and 6 h after in vitro exposure
to Ebola virions in comparison to mock-exposed cells. In parallel,
macrophages were treated with LPS to assess the responsiveness of
the cells and to compare the response to different stimuli as genes
responding to both virions and LPS might highlight possible
response pathways. In a second set of experiments, we distin-
guished between responses induced by virion binding/entry and
responses that require virus gene expression, cellular signals
occurring after virion entry by exposing macrophages to Ebola
VLPs. We found that Ebola virions exposure, as well as exposure
to VLPs can trigger most of the detected changes after 1 h of
exposure, and thus independent of virus replication.
Materials and Methods
Cells and viruses
Primary human macrophages were obtained from two sources.
For the first set of experiments, fresh elutriated primary human
monocytes from three donors (D1, D2, D3) were purchased from
Advanced Biotechnologies, Columbia, MD. For the second set of
experiments, primary human monocytes from three donors
(Poietics CD14
+, untreated 2W-400 series) (D4, D5, D6) were
purchased from Cambrex Bio Science Walkersville (Walkersville,
MD). For differentiation of monocytes into macrophages, cells
were cultivated in RPMI 1640 (Invitrogen, Carlsbad, CA)
containing 20% heat-inactivated human AB serum (Sigma-
Aldrich, St. Louis, MO), penicillin (100 U/ml), streptomycin
(100 mg/ml), and L-glutamine (2 mM). Human embryonic kidney
(HEK) 293T epithelial cells and grivet (Chlorocebus aethiops) kidney
epithelial Vero E6 cells (ATCC, Rockville, MD) were maintained
in DMEM (Invitrogen, Carlsbad, CA) containing 10% heat-
inactivated fetal bovine serum (Invitrogen, Carlsbad, CA),
penicillin (100 U/ml), streptomycin (100 mg/ml), and L-glutamine
(2 mM). All cells were incubated at 37uC in a humidified 5% CO2
environment. The Mayinga strain of Zaire ebolavirus (ZEBOV),
isolated in 1976 [2], was used for all infections, which were
performed under biosafety level 4 conditions at the National
Microbiology Laboratory of the Public Health Agency of Canada
in Winnipeg, Manitoba. Prior to use, virus stocks were propagated
in Vero E6 cells and clarified by centrifugation at 3,000 g for
10 min at 4uC. Supernatants were then layered on TNE buffer
(20 mM Tris [pH 7.5], 0.1 M NaCl, 0.1 mM EDTA) containing
20% sucrose and spun at 28,000 rpm at 4uC for 2 h by using an
SW28 rotor with a Beckman Optima L-70K ultracentrifuge. The
virion pellet was resuspended in RPMI 1640 and titers were
determined by plaque assay as previously described [25]. As a
control, supernatant from mock-infected Vero E6 cells was
purified and quantified by the same procedures.
Generation of virus-like particles
Generation and purification of virus-like particles (VLPs) were
performed as described elsewhere [19]. In brief, ZEBOV
VLPVP40-GP and VLPVP40 were generated by transient transfec-
tion of HEK 293T cells with plasmids encoding ZEBOV VP40
and/or ZEBOV GP1,2 [19] and quantitated by electron-
microscopic particle counting [26] and a DC protein assay
(BioRad, Mississauga, Ontario).
Negative-stain electron microscopy
Electron-microscopic evaluation of VLPs was performed on a
Phillips CM100 microscope with low dose software and Compu-
stage attachments. Negative staining was performed on formvar
carbon-coated copper grids (Electron Microscopy Sciences,
Hatfield, PA). Purified VLP solution (13 ml) was exposed to a
freshly glow-discharged grid for 2 min, and the grid then
transferred to a drop of 1% sodium silicotungstate (pH 7.5) for
Author Summary
Ebola virus causes a severe hemorrhagic fever syndrome in
man with high case-fatality rates. Following infection,
monocytes and macrophages are among the first cells
targeted by the virus. These cells respond by increasing
expression of inflammatory cytokines and chemokines
that contribute towards pathogenesis. In order to more
thoroughly characterize the host response to Ebola infec-
tion, primary human macrophages were infected with
Zaire ebolavirus and samples harvested for transcriptional
changes after 1 or 6 hours post infection. Whereas pre-
vious studies have analyzed a relatively small subset of
host genes, this study examined the transcriptional profile
of over 10,000 genes and employed rigorous pathway
analyses to the datasets. Ebola virus was found to signi-
ficantly regulate the expression of over 88 host genes.
These changes occurred within the first hours of infec-
tion. Subsequent experiments demonstrated that virus
replication was not necessary for activation. Indeed, non-
infectious virus-like particles expressing the ebolavirus
glycoprotein and matrix proteins were sufficient stimuli to
induce activation.
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paper at the edge of the grid. The grid was air dried for at least 1 h
before electron-microscopic examination. Images were recorded at
machine magnifications of 56,0006 and 72,0006 on Direct
Positive Film 5302 (Kodak, Rochester, NY).
Endotoxin test
Prior to use, virion stocks, mock stocks, VLPs, and media were
analyzed for endotoxin presence using the Limulus amebocyte
lysate test (BioWhittaker, Walkersville, MD).
Exposure of macrophages
Six days after seeding, growth medium of human macrophages
was replaced with fresh RPMI 1640 containing 2% human AB
serum, penicillin (100 U/ml), streptomycin (100 mg/ml), and L-
glutamine (2 mM). Cells were then incubated for one day at 37uC
in a humidified, 5% CO2 environment. Cells from donors D1, D2,
and D3 were infected with either mock virus preparation or
ZEBOV at a multiplicity of infection (MOI) of 10. Cells of donors
D4, D5, and D6 were infected with ZEBOV at an MOI of 100,
mock virus preparation, ,100 particles/cell VLPVP40-GP, ,100
particles per cell VLPVP40, mock VLP (plasmid only), ,100 latex
particles/cell, or 10 ng/ml of lipopolysaccharide (LPS). Cell
supernatants were removed from the cells 1 h or 6 h post
infection, and RNA from cells was purified using the RNeasy
Mini Kit (QIAGEN, Valencia, CA) according to the manufactur-
er’s instructions. The analysis of purified RNA from 10 MOI was
analyzed by DNA microarrays as outlined below. The RNA
obtained after infection with 100 MOI was subjected to
quantitative real-time RT-PCR analysis only.
Microarrays
Genechip technology from Affymetrix (Santa Clara, CA) was
used to study the transcriptional activity of human genes using the
human GeneChipH array HG-U95Av2 with a total of 12,626
probes representing approximately 10,000 full-length genes
(Affymetrix Technical Note to Human Genome U133 Genechip
set). Normalized signal values were generated from image raw data
and used to calculate p values indicating significance levels for
signal strength (absent or present call) and log2 ratio values in
comparison files (change, increase, decrease calls) using the
Affymetrix Microarray Suite 5.0 (MAS 5.0). Analysis was
performed on these normalized data with a reduced set of genes
after removing all genes that were absent on all arrays. The
remaining data included 8,861 probe sets. Additional data
reduction was achieved by excluding all genes that were identified
as ‘no change’ (NC) in all six experiments when comparing Ebola
virion-exposed with mock-exposed cells, respectively. The remain-
ing dataset included 2,025 upregulated or downregulated genes.
An analysis of variance (single factor ANOVA) and determination
of the correlation coefficient (R
2) of changes in gene expression
levels between ZEBOV-treated and VLP-treated cells was
performed using Microsoft Office Excel. Array data were
displayed on MA plots (Figure S1), i.e. on a scatter plot showing
the correlation between the average log2 intensity versus log2 ratio
for a ZEBOV-treated versus mock-treated pair of cells. Log
intensity was calculated as K (log(virion)+log(mock)). Genes
unchanged between test and control have a log2 value of zero;
downregulated genes have negative values; and upregulated genes
have positive values. Hierarchical clustering was performed using
Stanford’s GeneCluster and displayed with the TreeView program
[27]. Clustering selection used average linkage clustering with the
correlation uncentered.
Pathway analysis of differentially expressed genes
InnateDb (www.innatedb.com) is a publically available resource
which, based on levels of either differential gene expression,
predicts biological pathways based on experiment fold change
datasets [28]. Pathways are assigned a probability value (p) based
on the number of genes present for a particular pathway as well as
the degree to which they are differentially expressed or modified
relative to a control condition. For our investigation input data was
limited to the subset of 2,025 genes identified above. Additionally,
functional networks were created using Ingenuity Pathway
Analysis (IPA) software (Ingenuity Systems, Redwood City, CA).
Those genes with known gene symbols and their corresponding
expression values were uploaded and mapped to their corre-
sponding gene objects in the IPA Knowledge Base. Networks of
these genes were algorithmically generated based on their
connectivity and assigned a score. Genes are represented as
nodes, and the biological relationship between two nodes is
represented as an edge (line). The intensity of the node color
indicated the degree of up- or down-regulation. Genes in
uncolored notes were not identified as differentially expressed in
our experiment and were integrated into the computationally
generated networks on the basis of the evidence stored in the IPA
knowledge memory indicating a relevance to this network.
Relative quantification of transcript levels by real-time
PCR
Reverse transcription and subsequent quantitative real-time
polymerase chain reaction (qPCR) were performed as described
previously [19]. Strand-specific qPCR was performed using
strand-specific primers for the reverse transcriptase reaction. As
controls for non-specific or self-priming events, control reverse
transcriptase reactions lacking primer were performed in parallel.
Relative amounts of different strands were determined by
normalizing against the house-keeping gene GAPDH and by
subtracting the amounts of PCR product resulting from self-
priming from strand-specific products. Relative quantification was
performed using the comparative CT method (Applied Biosystems
User Bulletin #2, Dec. 11, 1997).
Results
DNA microarray data analysis
DNA microarray technology was used to determine the initial
response of human macrophages exposed to Ebola virions. Total
RNA isolated from primary human macrophages of three donors
(D1, D2, D3) at 1 h and 6 h after in vitro exposure to purified Ebola
virions was compared to RNA from mock-exposed cells derived
from the same donors. The time points were chosen as virus gene
expression does not occur within one hour of cell-virion contact,
whereas it will have commenced five hours later while ZEBOV
replication is still absent (see below). A total of 12 HG-U95Av2
GeneChip microarrays were analyzed to determine differences in
cellular gene expression levels between Ebola virion-exposed and
mock-exposed macrophages from donors D1–D3 and also
compared to the responses of LPS-treated cells. Genes detected
as absent (p#0.05) on all 12 arrays were removed from a total of
12,606 probe sets prior to ratio analysis resulting in a reduced
number of 8,861 probe sets. The log2 ratio was plotted as a
function of the average log2 intensity of Ebola virion-exposed
versus mock-exposed samples to test for hybridization quality and
for the extent of variation among biological replicates (cells from
the three donors). The MA plots for both the 1 h and 6 h time
points demonstrate a low variability among donors and good
overall reproducibility with the mean log2 being zero over the
EBOV-Induced Changes in Macrophage Gene Expression
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among donors was corroborated quantitatively by an analysis of
variance of the signal strength. A single factor analysis of variance
(ANOVA) indicated no significant difference among the 12 arrays
(p=0.83), confirming that the expression of the majority of cellular
genes was not affected by exposure to Ebola virions. Genes
responsive to Ebola virion exposure were identified by data
reduction, i.e. by exclusion of all genes that were identified as ‘no
change’ (NC, p#0.05) for all conditions tested. The resulting 2,025
probe sets (genes) were characterized by at least one significant
change in one donor at either 1 h or 6 h post infection. ANOVA
indicated that differences in expression patterns among these
probe sets were statistically significant (p=3 610
26).
The 2,025 genes identified were then screened for patterns of
cellular expression changes that could be biologically relevant.
Two types of selection criteria were designed to determine whether
expression of a cellular gene was significantly affected by Ebola
virion exposure, threshold-based criteria and trend-based criteria.
First, thresholds for fold-change, p-values, and signal strength were
established. Specifically, a minimum of a 2-fold-difference in
cellular gene expression levels in infected macrophages from at
least two of the three donors in at least one of the two time points
and p-values,0.05 were defined as pertinent (Figure 1). Second, it
was acknowledged that in the case of most genes the extent of
changes in gene expression required for a biological impact are
unknown. For instance, some genes might respond to virus
infection with only minor changes in expression levels that may
still be biologically relevant. Vice versa, rather dramatic changes
may prove to be biologically irrelevant. Consequently, trend
selection criteria were established to screen for a common
tendency or direction of changes in cellular gene expression
levels. Only changes with an associated p-value of #0.01 were
considered, and no unique cutoff value for fold-change was
specified. Accordingly, changes of less than 2-fold were accepted if
the direction of change in macrophages from all donors was the
same (all increased or all decreased). The two resulting gene sets
were analyzed by hierarchical clustering (Stanford Cluster
software) and the resulting clusters were visualized using TreeView
(Figures 1 & 2).
Application of the threshold-based selection criteria identified
205 cellular genes whose expression changed upon Ebola virion
exposure (Figure 1). Clustering of these 205 genes revealed two
subclusters. Gene subcluster 1 was characterized by extensive
expression variability across donors and time points. Inspection of
transcript levels (signal strength) revealed very low signals, which
may be a reason of the apparent variability among biological
replicates. In contrast, many genes in subcluster 2 show consistent
responses among all three donors in at least one time point.
However, there are some genes that show similar responses in
cluster 1. Since the overall variability in subcluster 1 could be due
to low signal strength the dataset of 205 genes was subjected to the
additional requirement that of the two compared signal levels the
higher one (i.e. mock-signal for upregulated genes, Ebola-signal for
downregulated genes) has a minimum signal value of 100 (signal
threshold). Fifty-one genes remained when this added threshold
criterion was applied. Most of them were located in subcluster 2
and are listed in Table S1 (threshold selection). The majority of the
51 genes were upregulated at 1 h post infection, at 6 h, or at both
time points.
The second set of criteria, designed for selecting a trend of
responses rather than assuming a threshold for fold-change,
yielded a total of 66 probe sets (63 genes) (see Figure 2 and Table
S1, trend selection). Approximately half of them were character-
ized by a fold-change of $2 and were also identified after the first
set of selection criteria was applied. A total of 88 genes were
identified after either criterion was applied. Among those 88 genes
from threshold and trend analysis (Table S1), 26 fulfilled both
Figure 1. Color-coded hierarchical cluster analysis. Threshold
Criteria: changes of gene expression levels in primary macrophages of
at least 2-fold (‘‘threshold’’) occurring in at least two of the three donors
in at least one of the two time points upon Ebola virion exposure
compared to mock exposure. Gene subcluster 1 is characterized by
expression variability across donors and time points. Subcluster 2 is
characterized by consistent responses among all 3 donors in at least
one time point.
doi:10.1371/journal.pntd.0001359.g001
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altered expression levels following exposure to Ebola virions in the
same direction as after treatment with LPS. Interestingly, the
expression levels of cellular genes identified by applying the trend
analysis (Table S1 & Figure 2), all changed at the 1 h time point.
Importantly, this set includes genes whose elevated expression was
previously associated with human Ebola virus disease, such as the
genes encoding CXCL1, IL-1b, IL-6, IL-8, and TNF-a [6,11], as
well as genes previously unknown to play a role in Ebola virus
disease, such as those encoding CCL-20, COX-2, IL-15 receptor
a, phosphodiesterase 4B, and t-Pa. Expression levels of almost all
identified genes were upregulated, with the exception of genes
encoding GNA13, CREM, and LILRB2 at the 1 h time point and
MRPS6, GADD45, and DUSP2 at the 6 h time point.
Figure 2. Cluster analysis of genes selected by Trend Criteria. Changes of gene expression levels occurred in primary macrophages from all
three donors (‘‘trend’’) in at least one time point in the same direction with p-values,0.01. Red and green colors represent upregulation and
downregulation, respectively. Intensity of colors reflects intensity of changes in gene expression.
doi:10.1371/journal.pntd.0001359.g002
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of the node color indicates the degree of up (red)- or down (green)-regulation. Genes in uncolored nodes were not identified as differentially
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Recently, the integration of bioinformatics to complex biological
data sets has provided a network-based approach for delineating
the host response. As cellular responses are mediated through the
selective activation or repression of signaling pathways we sought to
integrate our gene expression data into functional signaling
networks. Functional networks were created from our biological
data sets using Ingenuity Pathway Analysis (IPA) (Figure 3). Genes
belonging to these functional networks were related to cell-to-cell
signaling and interactions, hematological system development and
function, immune cell trafficking, inflammatory response and cell
movement. To expand on the biological significance of this
analysis, and identify individual signaling pathways modulated
following infection, we performed pathway over-representation
analysis (ORA) with the online software tool InnateDB (www.
innatedb.com)[28]andanalyzed the1 hand 6 hEbola-infected vs.
mock-infected comparative data sets. Integrated data was limited to
the 2,025 genes identified above and fold-changes .1.5 and
associated p-values.0.01 were chosen as parameters for pathway
ORA. The resultant differentially regulated pathways with p-
values,0.1 are presented in Tables 1 and 2.
Pathway ORA of the data set for the 1 h Ebola-infected vs. mock-
infected treatments identified a number of pathways directly related
to activation of the G-protein coupled receptor pathway (Table 1). As
chemokines and inflammatory mediators activate GPCR signaling
this correlates with previous investigations demonstrating increased
secretion of cytokines and chemokines following Ebola virus insult
[16,18]. It was also demonstrated that many of the genes identified as
central nodes in the IPAfunctional networks (IL-6, IL-10, IRF-7, etc.)
also occupied central positions in the signaling pathways identified
with InnateDB (heterotrimeric GPCR signaling pathways). Indeed,
the upregulation of pathways related to interleukin (IL)-2, IL-12, IL-
23 and IL-27 signaling pathways were also identified as being
differentially upregulated in Ebola-infected cells as compared to the
mock-infected treatment (Table S1). Further, GPCR-related signal-
ing pathways (cytokine-cytokine receptor interaction pathway) and
the Jak-Stat signaling pathway were also upregulated during the
immediate response to infection. Interestingly, pathways related to
fibrinolysis (dissolution of fibrin clot pathway; fibrinolysis pathway)
were also upregulated by Ebola infection as compared to the mock-
infected control (Table 1). Previously, dysregulation of the fibrinolytic
system was recognized in Ebola-infected macaques [13]. A limited
number of downregulated pathways were identified in our analysis as
being significantly downregulated at 1 h post-infection and were
largely related to metabolic processes as well as inhibition of the
negative regulation of GPCR signaling (Table 1).
Incontrast,differentiallyupregulated signaling responsesatthe6 h
time point were largely related to cell adhesion (syndecan-1-mediated
signaling events), metabolism (prostaglandin and leukotriene metab-
olism; arachidonic acid metabolism; steroid hormone metabolism)
and cytokine/chemokine signaling (cytokine-cytokine receptor inter-
action; chemokine signaling pathway; chemokine receptors bind
chemokines) (Table 2). Interestingly, there was a large increase in the
number of downregulated pathways at the 6 h time point as
compared to the 1 h time point. Multiple pathways belonging to
transcription and nucleotide/nucleoside metabolism were identified
as being significantly downregulated in Ebola-infected cells as
compared to the mock-infected controls 6 h post-infection (Table 2).
Comparison of the differentially regulated pathway ORA data sets
between the 6 h Ebola-infected vs. mock-infected and LPS-
stimulated vs. mock-stimulated treatments demonstrated minimal
overlap of upregulated or downregulated pathways (data not shown).
Whereas LPS stimulation resulted in the upregulation of pathways
largely related to TNF-a, Toll-like receptor (TLR) or apoptosis
signaling pathways these were not identified in the Ebola-infected
samples. Thus, this likely indicates that the pro-inflammatory
response to Ebola may be largely repressed by a yet unidentified
mechanism at early time points following infection.
Real-time RT-PCR quantification of changes in cellular
gene expression levels
DNA microarrays are sensitive and specific in identifying
regulated transcripts, but the technique commonly leads to
underestimation of the degree of fold-change in gene expression.
Comparison of the fold-changes in gene expression determined by
DNAmicroarraystoastandardizedquantitativereal-timeRT-PCR
demonstrated that the underestimation error was larger when the
fold-change differences were higher, corresponding to the finding
that the quantitative range of real-time RT-PCR is larger than of
DNA microarrays [29]. Consequently, real-time RT-PCR was
performed for a subset of 16 selected genes that fulfilled at least one
of the selection criteria to verify the results obtained by DNA
microarray analysis. Some of the selected genes served as controls
and are known to be influenced by ZEBOV infection, however, not
necessarily at these early time points (TNF-a, IL-1b, IL-6, IL-8,
CXCL1, RANTES, IL-10). Some genes were selected according to
their potential relevance in infection due to their known functions
and roles in modulation of immune response, viral infections or
signaling pathways (hCOX-2, CCL20, 4-1BB, CSF-1, G-CSF,
INDO, RSAD2, t-PA, DDX5).Verification was achieved when the
direction of gene expression levels was identical and when the
expression level changes determined by real-time PCR were equal
or stronger than those determined by DNA microarray analysis.
Figure 4 illustrates the comparison of the results of microarray
analysis and real-time PCR quantifications over both time points.
Real-time PCR confirmed the direction of changes in gene
expression levels determined by microarray analysis and verified
that most changes in cellular gene expression already occurred at
the 1 h time point. In particular, upregulation of genes known to
play an important role in Ebola hemorrhagic fever (CXCL-1, IL-
1b, IL-6, IL-8, and TNF-a [6,11]) was verified, although some
variation was seen among donors.
Response triggering of macrophages upon ZEBOV
binding/entry
The observation that most cellular responses occurred within
1 h after exposure to Ebola virions suggested that virion binding/
expressed in our experiment and were integrated into the computationally generated networks on the basis of the evidence stored in the IPA
knowledge memory indicating a relevance to this network. A. Network 1 at 1 h post-infection - Cell-To-Cell Signaling and Interaction, Hematological
System Development and Function, Immune Cell Trafficking; B. Network 2 at 1 h post-infection – Inflammatory Response, Cellular Movement,
Hematological System Development and Function; C. Network 3 at 1 h post-infection – Cellular Movement, Hematological System Development and
Function, Immune Cell Trafficking. D. Network 1 at 6 h post-infection - Cell-To-Cell Signaling and Interaction, Hematological System Development
and Function, Immune Cell Trafficking; E. Network 2 at 6 h post-infection – Inflammatory Response, Cellular Movement, Hematological System
Development and Function; F. Network 3 at 6 h post-infection – Cellular Movement, Hematological System Development and Function, Immune Cell
Trafficking.
doi:10.1371/journal.pntd.0001359.g003
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Pathway Name Source Name
Genes in
Pathway
Genes With
Increased
Expression
Up-Regulated
Pathway
P Value
Genes With
Decreased
Expression
Down-Regulated
Pathway
P Value
Heterotrimeric GPCR signaling pathway (through G
alpha s ACs PKA BRaf and ERK cascade)(canonical) (GPCR
signaling (G alpha s, PKA and ERK))
INOH 43 16 0.00088 4 0.93421
Heterotrimeric GPCR signaling pathway (through G alpha
i and pertussis toxin) (GPCR signaling (pertussis toxin))
INOH 37 14 0.00156 3 0.95254
Heterotrimeric GPCR signaling pathway (through G
alpha s ACs Epac BRaf and ERKcascade) (GPCR signaling
(G alpha s, Epac and ERK))
INOH 37 14 0.00156 3 0.95254
Heterotrimeric GTP-binding protein coupled receptor
signaling pathway (through G alpha i, adenylate
cyclase and cAMP) (GPCR signaling (G alpha i))
INOH 37 14 0.00156 3 0.95254
Heterotrimeric GTP-binding protein coupled receptor
signaling pathway (through G alpha s, cholera toxin,
adenylate cyclase and cAMP) (GPCR signaling (cholera toxin))
INOH 40 14 0.00370 3 0.96827
Heterotrimeric GPCR signaling pathway (through G alpha
q, PLC beta and ERK cascade) (GPCR signaling (G alpha q))
INOH 42 14 0.00613 2 0.99481
Dilated cardiomyopathy KEGG 15 7 0.00674 2 0.72108
Jak-STAT signaling pathway KEGG 47 15 0.00725 3 0.98807
Arrhythmogenic right ventricular cardiomyopathy (ARVC) KEGG 12 6 0.00814 1 0.87865
IL27-mediated signaling events PID NCI 13 6 0.01302 0 1
ATF-2 transcription factor network PID NCI 17 7 0.01507 1 0.95001
African trypanosomiasis KEGG 17 7 0.01507 0 1
Graft-versus-host disease KEGG 7 4 0.01818 1 0.70683
Calcium signaling in the CD4+ TCR pathway PID NCI 11 5 0.02529 0 1
Cytokine-cytokine receptor interaction KEGG 73 19 0.02729 8 0.92362
Amine ligand-binding receptors REACTOME 2 2 0.02846 0 1
Dissolution of Fibrin Clot REACTOME 2 2 0.02846 0 1
Dual incision reaction in TC-NER REACTOME 2 2 0.02846 0 1
Fibrinolysis pathway PID BIOCARTA 2 2 0.02846 0 1
Formation of transcription-coupled NER (TC-NER) repair complex REACTOME 2 2 0.02846 0 1
IL-2 signaling pathway (JAK1 JAK3 STAT5) (IL-2 signaling
(JAK1 JAK3 STAT5))
INOH 2 2 0.02846 0 1
Multi-drug resistance factors PID BIOCARTA 2 2 0.02846 0 1
Allograft rejection KEGG 8 4 0.03163 1 0.75415
IL12-mediated signaling events PID NCI 24 8 0.03646 2 0.91823
Class B/2 (Secretin family receptors) REACTOME 5 3 0.03654 0 1
IL23-mediated signaling events PID NCI 20 7 0.03829 1 0.97070
Malaria KEGG 20 7 0.03829 1 0.97070
Negative feedback regulation of JAK STAT pathway by
(cytokine receptor degradation signaling) (JAK-STAT
pathway and regulation pathway Diagram)
INOH 21 7 0.04948 1 0.97549
Type I diabetes mellitus KEGG 9 4 0.04956 1 0.79387
Coregulation of Androgen receptor activity PID NCI 10 1 0.84457 5 0.01268
S1P4 pathway PID NCI 4 0 1 3 0.01430
Amine compound SLC transporters REACTOME 2 0 1 2 0.02556
Na+/Cl2 dependent neurotransmitter transporters REACTOME 2 0 1 2 0.02556
Overview of telomerase rna component gene hterc
transcriptional regulation
PID BIOCARTA 2 0 1 2 0.02556
Regulation of CDC42 activity PID NCI 2 0 1 2 0.02556
Metabolism of non-coding RNA REACTOME 8 0 1 4 0.02632
SnRNP Assembly REACTOME 8 0 1 4 0.02632
N-Glycan biosynthesis KEGG 5 0 1 3 0.03156
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hypothesis is based on the absence of virus protein expression
during the first hour of virion exposure. To investigate this
assumption, real-time RT-PCR quantification, specific for either
the negative-stranded ZEBOV genome (vRNA) or for the positive-
stranded complementary ZEBOV cRNAs, was performed on
RNA purified from macrophages at 1 h and 6 h after virion
exposure. The obtained data (Figure 5) confirmed that at 1 h
cRNA amounts were below that of genomic RNA, whereas after
6 h cRNA was greatly increased.
LPS served as a positive control for the responsiveness of the
macrophages used in the virion exposure studies. A comparison of
the effects of Ebola virion exposure versus LPS treatment revealed
that the majority of genes responded similarly (Supplemental
Table 1), further substantiating the hypothesis that the observed
responses with Ebola virions were triggered by binding and/or
entry. To further investigate which changes in expression levels in
macrophages occur due to virion binding/entry, macrophage
responses following exposure with infectious virions were directly
compared to exposure to Ebola virus-like particles (VLPs) lacking
viral genetic material and containing only the ZEBOV matrix
protein VP40 and the ZEBOV spike glycoprotein GP1,2 (VLPVP40-
GP) (see also [19]). GP1,2 is the only known surface-exposed
structural component of Ebola virions and contains the cell-surface
receptor-binding domain [30,31]. We therefore hypothesized that
if virion binding is responsible for the observed macrophage
responses, then these effects would be mediated by GP1,2.T o
evaluate the role of GP1,2, VLPs consisting of VP40, but lacking
GP1,2 (VLPVP40), were tested in parallel with VLPVP40-GP.
VLPVP40 particles were shown previously to be morphologically
similar to the GP1,2-containing VLPs [32,33]. LPS was again used
as a control for macrophage responsiveness and also to directly
compare the LPS-induced responses to those of Ebola virion and
VLP exposures. Additionally, cells were exposed to latex particles,
which were used in approximate equal quantity to VLPs. Ebola
VLP preparations were tested by negative-stain electron micros-
copy for authentic appearance and presence (VLPVP40-GP)o r
absence (VLPVP40)o fG P 1,2 (data not shown). Particles resembled
those previously described [32,33]. In addition, Ebola virion, VLP,
and latex preparations were tested for endotoxin-contamination
before incubation with macrophages from donors D4, D5, and
D6. The endotoxin concentrations of all samples used in this study
were not above those of the tissue culture media (,0.5 U/ml). To
determine whether the quantitative differences in gene expression
levels between cells of donors D1–D3 observed in the first
experiment were due to the MOI used, a higher MOI of Ebola
virions (<100) was used for this experiment. Cells were exposed to
VLPs and latex particles at a concentration of 100 particles per
cell. LPS was used at the same concentration as in the first
experiment (10 ng/ml), which allowed for a direct comparison of
the responsiveness of macrophages used in both experiments. The
results revealed that while a higher MOI did increase the overall
intensity of responses compared to the first experiments (compare
to Figure 4), it did not eliminate or noticeably reduce the degree of
variation of gene expression levels between donors (Figure 6C &
6D). This suggests that genetic variation among identical cell types
of different donors may have an influence on the effect of ZEBOV
infection and therefore may influence chances of survival.
Since all stimuli were given in parallel to macrophages from
each donor, this experiment allowed for a direct qualitative
comparison of the cellular responses to the different stimuli.
Cellular gene expression levels were determined by real-time RT-
PCR specific for 21 genes that were selected from the list of genes
established using DNA microarray analysis in the first experiment.
These 21 genes included the majority of genes previously analyzed
by real time PCR (Figure 4), as well as additional genes that were
suspected or known to play a role in ZEBOV infection in vivo.
a) Main clusters
The results of the real-time PCR quantification were analyzed
by two-dimensional cluster analysis. The first clustering was
performed to group genes according to similar behavior in
expression changes (upregulation or downregulation) following a
stimulus (Figure 6A). This first cluster was then used for clustering
in a second dimension to group experimental stimuli according to
similar effects they had on changes in gene expression (Figure 6A,
right cluster). Analysis revealed genes that were upregulated at the
1 h and then downregulated at the 6 h time point (GADD45,
DUSP2, IL-10), genes that were first downregulated and then
upregulated (IDO, ISG 45K), a large group of genes induced at
both time points, and finally genes that were downregulated at
both time points (TLR3, GNA13). The second clustering ordered
the experimental groups according to similar responses in gene
expression (Figure 6B) and revealed the following three major
clusters: 1) 1 h exposure to Ebola virions, LPS, and VLPVP40-GP,2 )
6 h exposure to Ebola virions, LPS, and VLPVP40-GP, and 3) 1 h
Pathway Name Source Name
Genes in
Pathway
Genes With
Increased
Expression
Up-Regulated
Pathway
P Value
Genes With
Decreased
Expression
Down-Regulated
Pathway
P Value
Negative regulation of (G alpha i GDP-GTP exchange
signaling) (GPCR signaling (G alpha i))
INOH 5 0 1 3 0.03156
Negative regulation of (G alpha i GDP-GTP exchange
signaling) (GPCR signaling (pertussis toxin))
INOH 5 0 1 3 0.03156
RNA transport KEGG 21 1 0.98041 7 0.03816
CXCR3-mediated signaling events PID NCI 9 1 0.81260 4 0.04155
Metabolism of RNA REACTOME 13 1 0.91143 5 0.04308
Differential host signaling pathway modulation identified by pathway ORA through the direct comparison of mock-infected and EBOV-infected macrophages 1 hr post-
infection. The online software InnateDB was utilized for pathway over-representation analysis. Based on levels of differential expression InnateDB is able to predict
pathways that are consistent with the experimental data. Pathways are assigned a probability value (p) based on the number of proteins present for a particular
pathway. It also provides the number of uploaded pathways associated with a particular pathway as well as the subset of individual genes that are differentially
expressed.
doi:10.1371/journal.pntd.0001359.t001
Table 1. Cont.
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Pathway Name Source Name
Genes in
Path-way
Genes With
Increased
Expression
Up-Regulated
Pathway
P Value
Genes With
Decreased
Expression
Down-Regulated
Pathway
P Value
Syndecan-1-mediated signaling events PID NCI 5 5 0.00023 0 1
Cytokine-cytokine receptor interaction KEGG 73 25 0.00095 7 0.99528
Signaling by GPCR REACTOME 56 20 0.00178 11 0.56426
Chemokine signaling pathway KEGG 55 19 0.00362 5 0.99167
Nicotinate and Nicotinamide metabolism INOH 5 4 0.00536 0 1
Peptide ligand-binding receptors REACTOME 20 9 0.00644 4 0.57903
Prostaglandin and Leukotriene metabolism INOH 3 3 0.00673 0 1
Chemokine receptors bind chemokines REACTOME 12 6 0.01446 2 0.71951
Nicotinate and nicotinamide metabolism KEGG 4 3 0.02315 0 1
G alpha (q) signalling events REACTOME 21 8 0.03083 2 0.94103
Cardiac muscle contraction KEGG 2 2 0.03581 0 1
Lysosphingolipid and LPA receptors REACTOME 2 2 0.03581 0 1
Regulation of CDC42 activity PID NCI 2 2 0.03581 0 1
Regulation of beta-cell development REACTOME 2 2 0.03581 0 1
CD4 T cell receptor signaling (through Vav, Rac and JNK
cascade (CD4 T cell receptor signaling (JNK cascade))
INOH 11 5 0.04013 2 0.67174
Antigen processing and presentation KEGG 8 4 0.04658 2 0.48975
Arachidonic acid metabolism KEGG 5 3 0.04984 1 0.66788
Steroid hormone biosynthesis KEGG 5 3 0.04984 1 0.66788
RNA Polymerase I Transcription REACTOME 5 0 1 4 0.00626
ATP+ADP=ADP+ATP (Purine nucleotides and Nucleosides
metabolism)
INOH 3 0 1 3 0.00760
ATP+CDP=ADP+CTP (Pyrimidine Nucleotides and
Nucleosides metabolism)
INOH 3 0 1 3 0.00760
ATP+GDP=ADP+GTP (Folate metabolism) INOH 3 0 1 3 0.00760
ATP+GDP=ADP+GTP (Purine nucleotides and Nucleosides
metabolism)
INOH 3 0 1 3 0.00760
ATP+IDP=ADP+ITP (Purine nucleotides and Nucleosides
metabolism)
INOH 3 0 1 3 0.00760
ATP+UDP=ADP+UTP (Pyrimidine Nucleotides and
Nucleosides metabolism)
INOH 3 0 1 3 0.00760
ATP+dADP=ADP+dATP (Purine nucleotides and
Nucleosides metabolism)
INOH 3 0 1 3 0.00760
ATP+dCDP=ADP+dCTP (Pyrimidine Nucleotides and
Nucleosides metabolism)
INOH 3 0 1 3 0.00760
ATP+dGDP=ADP+dGTP (Purine nucleotides and
Nucleosides metabolism)
INOH 3 0 1 3 0.00760
ATP+dIDP=ADP+dITP (Purine nucleotides and Nucleosides
metabolism)
INOH 3 0 1 3 0.00760
ATP+dTDP=ADP+dTTP (Pyrimidine Nucleotides and
Nucleosides metabolism)
INOH 3 0 1 3 0.00760
ATP+dUDP=ADP+dUTP (Pyrimidine Nucleotides and
Nucleosides metabolism)
INOH 3 0 1 3 0.00760
Post-Elongation Processing of Intronless pre-mRNA REACTOME 3 0 1 3 0.00760
Processing of Capped Intronless Pre-mRNA REACTOME 3 0 1 3 0.00760
Processing of Intronless Pre-mRNAs REACTOME 3 0 1 3 0.00760
Transcription REACTOME 20 2 0.91737 9 0.00852
RNA Polymerase I, RNA Polymerase III, and Mitochondrial
Transcription
REACTOME 9 0 1 5 0.01808
Cleavage of Growing Transcript in the Termination Region REACTOME 4 0 1 3 0.02597
MRNA 39-end processing REACTOME 4 0 1 3 0.02597
Post-Elongation Processing of Intron-Containing pre-mRNA REACTOME 4 0 1 3 0.02597
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suggests that Ebola virions, LPS, and VLPVP40-GP caused strikingly
similar responses in comparison to the responses to VLPVP40 and
latex particles. This further supports the notion that binding/entry
of virions mediated by GP1,2 plays a significant role in the host
response to infection. Thirteen of the 21 genes tested responded to
Ebola virions, VLPVP40-GP, and LPS at both time points. TNF-a,
IL-1b, IL-6 and IL-8 were also found in a separate study on the
effects of VLPs on macrophages [19] and CXCL1 represents a
gene known to be affected by ZEBOV infection. However, COX-
2, GCH1, GM-CSF, MIP-3a, t-Pa, GADD45A, and IDO (6 h)
are genes identified to play a role in Ebola hemorrhagic fever for
the first time.
b) Subclusters
Within the first two clusters, various subclusters were identified.
One revealed that out of the 13 genes that were upregulated at
both time points, 9 responded, albeit weakly, to VLPVP40 at the
1 h time point. This supports the notion that the matrix protein
VP40 might also be involved in cellular interactions upon
binding/entry, which may participate in triggering part of the
detected responses in macrophages, mainly involved in proin-
flammatory signaling. Exposure to latex particles did not induce a
response, indicating that the signals mentioned above were not
due to non-specific cellular uptake of particles. Another subcluster
differentiated macrophages treated with VLPVP40-GP versus Ebola
virions or LPS and included IFN-inducible genes such as RSAD2
and IFIT2, as well as G-CSF, TF, GADD45, DUSP2, IL-10,
IDO, and CD 137lig. Another sub-cluster revealed 3 genes,
DUDP2, IL-10, and TLR3, which were downregulated at the 6 h
time point, and one gene, GNA13, which was downregulated at
both time points by Ebola virions or VLPVP40-GP but not by LPS.
c) Mixing clusters
At the 1 h time point, cells responded to Ebola virions and LPS
by upregulating GADD45A, DUSP2, and IL-10, whereas these
genes were downregulated at the 6 h time point. Both stimuli
(virions and LPS) resulted in upregulation at both time points of
TF and 4-1BB. The IFN-inducible genes RSAD2 and IFIT2, G-
CSF (CSF-3), and GNA13 responded at the 1 h time point to both
Ebola virions and VLPVP40-GP and at the 6 h time point to both
Ebola virions and LPS. One possible explanation for this delayed
response might be differences in the kinetics of the responses
between the LPS and virions or VLPVP40-GP stimuli. Of the genes
that responded to only two of the presented stimuli, more genes
reacted similarly to virions and LPS than to virions and VLP. A
Pathway Name Source Name
Genes in
Path-way
Genes With
Increased
Expression
Up-Regulated
Pathway
P Value
Genes With
Decreased
Expression
Down-Regulated
Pathway
P Value
Post-Elongation Processing of the Transcript REACTOME 4 0 1 3 0.02597
RNA Polymerase I Promoter Clearance REACTOME 4 0 1 3 0.02597
RNA Polymerase I Transcription Initiation REACTOME 4 0 1 3 0.02597
RNA Polymerase I Transcription Termination REACTOME 4 0 1 3 0.02597
RNA Polymerase II Transcription Termination REACTOME 4 0 1 3 0.02597
Stabilization and accumulation of cytoplasmic beta-catenin
(Canonical) (Canonical Wnt signaling pathway Diagram)
INOH 4 1 0.56935 3 0.02597
Stabilization and accumulation of cytoplasmic beta-catenin
(Canonical) (Mammalian Wnt signaling pathway Diagram)
INOH 4 1 0.56935 3 0.02597
Stabilization and accumulation of cytoplasmic beta-catenin
(Mammal) (Mammalian Wnt signaling pathway Diagram)
INOH 4 1 0.56935 3 0.02597
L1CAM interactions REACTOME 7 1 0.77162 4 0.03141
Rb tumor suppressor/checkpoint signaling in response
to dna damage
PID BIOCARTA 7 0 1 4 0.03141
Neuroactive ligand-receptor interaction KEGG 28 6 0.44392 10 0.03403
Activated TAK1 mediates p38 MAPK activation REACTOME 2 0 1 2 0.03883
Amine ligand-binding receptors REACTOME 2 0 1 2 0.03883
Glutathione conjugation REACTOME 2 0 1 2 0.03883
Leukotriene synthesis REACTOME 2 0 1 2 0.03883
Multi-drug resistance factors PID BIOCARTA 2 0 1 2 0.03883
Nef-mediates down modulation of cell surface receptors
by recruiting them to clathrin adapters
REACTOME 2 0 1 2 0.03883
Netrin mediated repulsion signals REACTOME 2 0 1 2 0.03883
Polyadenylation of mrna PID BIOCARTA 2 0 1 2 0.03883
Recycling of bile acids and salts REACTOME 2 0 1 2 0.03883
Synthesis of bile acids and bile salts via 7alpha-
hydroxycholesterol
REACTOME 2 0 1 2 0.03883
Differential host signaling pathway modulation identified by pathway ORA through the direct comparison of mock-infected and EBOV-infected macrophages 6 hr post-
infection. The online software InnateDB was utilized for pathway over-representation analysis as in Table 1.
doi:10.1371/journal.pntd.0001359.t002
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exposure is depicted in Figures 6C and D for the 1 h and 6 h time
points, respectively. Overall, the cluster analysis and the graphs
depicting the real-time RT-PCR quantifications indicate that
there was, in general, a significant correlation between the effects
of virions and effects of VLPVP40-GP with correlation coefficients of
R
2 of 0.746 and 0.9177 at the 1 h and 6 h time points,
respectively. In fact, the difference consists of the expression
patterns of G-CSF, 4-1BB, TF, RSAD2 (at 6 h only), and DUSP2,
which are the genes identified in the sub-clusters. The real-time
RT-PCR also revealed that the changes on gene expression of IL-
10, GNA13 and TLR3 are not significantly changed at these early
time points even at 100 MOI infection.
Discussion
The current study represents the first broad analysis of initial
transcriptional responses to Ebola virions of human macrophages,
the primary target cells of ZEBOV [12,13,14,15]. To assure
accurate identification of cellular genes that responded signifi-
cantly to virion exposure, DNA microarray data were scrutinized
and stringently filtered by two different sets of selection criteria
Figure 4. Comparison of DNA microarray and real-time PCR data. DNA microarray results and real-time RT-PCR quantification of changes in
cellular expression levels of 16 selected human macrophages genes after 1 h (A) or 6 h (B) post exposure to Ebola virions. Data are expressed as fold-
change of cellular gene expression. Data represent the median value for donors 1, 2, and 3.
doi:10.1371/journal.pntd.0001359.g004
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selected genes were experimentally verified by real-time PCR
analysis. Using these methods for statistical verification and assay
evaluation, our study permitted the identification of a large
number of genes not previously implicated in early cellular
responses to ZEBOV infection. The detected changes of gene
expression levels occurred within the first hours after primary
human macrophages were exposed to Ebola virions in vitro.I n
addition, we identified genes whose expression is known to be
upregulated during acute Ebola hemorrhagic fever. This not only
validated the experimental approach and data screening criteria, it
also demonstrated that elevated levels of gene products, such as
cytokines, are already induced in primary target cells within the
first hours of virion binding and entry. Lending further credence to
these assertions, pathway ORA of the significantly differentially
regulated genes identified from our gene expression studies
demonstrated a strong upregulation of specific host signaling
pathways related to cytokine/chemokine signaling during the
immediate response to Ebola infection. Indeed, the upregulation of
signaling pathways related to cytokine/chemokine signaling events
suggests that specific innate immune responses are mounted
during the acute phase of Ebola viral insult. Through multiple
pathway ORA analyses we identified broad cellular functional
networks that are modulated during the early course of Ebola
infection and, importantly, have correlated this with specific cell
signaling pathways. The identities of the individual signaling
pathways modulated by Ebola infection will provide critical
information regarding disease pathogenesis and as well informa-
tion for the development of novel antiviral therapeutics.
Some of the genes that had already been implicated in the
pathogenesis of Ebola hemorrhagic fever such as IL-6 and TNF-a
[6,11] were induced after 1 h, but returned towards basal levels of
expression after 6 h. Indeed, whereas LPS stimulation resulted in
the activation of a large subset of TNF-a related signaling
pathways at the 6 h time point there were no common pathways
identified in the Ebola-infected pathway ORA. Similar results
were obtained in another study, during which primary human
macrophages, exposed to Ebola VLPVP40-GP for 24 h, were
characterized by IL-1b, IL-6, IL-8, RANTES, and TNF-a
expression that also peaked at 1 h or 6 h before receding to base
levels [19]. These results contradict observations in vivo, which
demonstrated upregulation of cytokines for extended periods of
time [6,7,8,9,10,11]. It is plausible that the early cytokine peak
observed following high MOI infections in vitro is only achieved at
a later time during in vivo infection. Another possible explanation
for this difference is the duration of stimuli and thereby the
duration of responses. For instance, in vivo, progeny virions are
continuously produced by ZEBOV-infected cells and will
therefore bind to and enter additional target cells, resulting in
continuous stimuli that may maintain cytokine production and
facilitate prolonged activation. Therefore, our in vitro approach
most likely yielded results that are indicative of what continuously
occurs in vivo. That increased cellular gene expression levels result
in increased protein concentrations within 6 h was previously
demonstrated in a study that used human macrophages exposed to
VLPVP40-GP and ELISA measuring protein levels of IL-1b, IL-6,
IL-8, TNF-a [19].
The identified cellular genes whose expression levels were
altered after exposure to Ebola virions belonged to different
functional categories (Table S1). These genes include inflamma-
tory cytokines, molecules that regulate blood coagulation (such as
t-Pa, MMP-1, and serpine 1 and 2) genes involved in stress-
response, DNA repair, cell cycle arrest, and cell adhesion. In
support of these functional categories, our pathway ORA also
resulted in similar functional categorization of the differentially
regulated signaling pathways following Ebola virus infection. The
detection of a group of genes that responded to binding/entry of
Ebola virions, VLPVP40-GP, as well as to LPS raises the question
whether LPS and Ebola virions share receptors on the macro-
phage surface. Whereas receptors for Ebola virions on target cells
remain elusive, it is known that LPS induces its effects by binding
to TLR4 and MD2 and CD14 co-receptors. Recent studies
demonstrated that Ebola VLPVP40-GP, but not VLPVP40, induced
cytokine and SOCS1 expression in a TLR4/MD2 dependent
manner both in a human monocytic cell line (THP-1 cells) and in
293T cells expressing a functional TLR4/MD2 receptor [34]. The
innate immune defense is achieved by activating NF-kB and type I
IFN responses. It is already known that ZEBOV suppresses the
host cell antiviral response by inhibiting interferon signaling via its
VP35 and VP24 proteins [35,36,37,38,39,40,41], and RNA
silencing via VP35 [42]. Our studies revealed only limited IFN
signaling in Ebola virion-exposed macrophages compared to those
exposed to LPS, indicating that IFN signaling is inhibited early
upon infection.
The host response to virulent pathogens is likely to fall into two
categories [21]. First, there are common responses to unrelated
pathogens, such as the type 1 IFN innate immune response that
renders uninfected neighboring cells resistant to virus infection.
Second, there are responses specific for individual pathogens. On
the other hand, pathogens have evolved to counter these responses
to ensure their own survival and transmission. Examples are how
viruses of disparate families overcome the antiviral action of
apolipoprotein B mRNA editing enzyme, catalytic polypeptide-
like 3G (APOBEC3G) [43], tripartite motif containing 5
(TRIM5a) [44], bone marrow stromal cell antigen 2 (BST-2)/
tetherin [45,46,47], or interferon induced transmembrane proteins
(IFITM) [46,48,49]. It is important to remember that this study
partially characterizes the response of humans to ZEBOV
infection and that humans are not natural hosts of this virus.
Therefore, host responses and virus counteractions are not in a
state of equilibrium. It is therefore a fundamentally interesting
question whether infected humans succumb to Ebola hemorrhagic
fever because of direct effects exerted by the virus on the body or
because of overbearing immune responses by the individual.
Figure 5. Strand-specific detection ZEBOV RNA. Strand-specific
detection of the negative-stranded genomic ZEBOV GP RNA and the
positive-stranded ZEBOV GP cRNAs by real-time RT-PCR performed on
RNA purified from macrophages of donors D2 and D4 at 1 h and 6 h
after virion exposure. All values are normalized to total RNA.
doi:10.1371/journal.pntd.0001359.g005
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potential filovirus reservoirs that seemingly remain unaffected by
infection [50,51]. It is therefore tempting to repeat our studies with
cells from these animals to see whether their responses to Ebola
virion exposure are fundamentally different.
Taking together, our data indicate that the immediate responses
of early cellular ZEBOV targets in the human organism derive
from virion binding/entry mediated by the ZEBOV spike
glycoprotein and do not require virus gene expression. The fact
that many surveyed genes responded similarly to VLPVP40-GP, but
not to VLPVP40, treatment clearly supports this notion. However,
the fact that some genes, such as those encoding TF or skin
collagenase, were triggered only by Ebola virions but not
VLPVP40-GP or LPS indicate that these genes must be influenced
by factors other than virus binding or entry, such as other
components packaged within Ebola virions in addition to GP1,2
and VP40. In this regard, it is important to remember that
infectious Ebola virions not only consist of seven structural
proteins (NP, VP35, VP40, GP1,2, VP30, VP24, and L) but also
contain cellular transmembrane proteins that are usurped by
budding virions [52].
Supporting Information
Figure S1 MA plot depicting the overall distribution of
gene expression changes as a function of average signal
intensity for human macrophages obtained from three
different donors. Each data set compares gene expression levels
Figure 6. Determination of relative changes in expression levels of 21 cellular genes in primary human macrophages. Depicted are
fold-changes at the 1 h and 6 h time points after exposure to Ebola virions compared to mock-exposed cells, cells exposed to purified Ebola virion-
like particles (VLPs) containing VP40 and GP1,2 (VLPVP40-GP) or VLPs containing VP40 only (VLPVP40), or cells treated with mock-VLP preparation. As
controls, macrophages of each donor were treated in parallel with latex beads or with 10 ng of LPS. (A) Color-coded first dimension hierarchal cluster
analysis based on average linkage clustering of the fold-changes in cellular gene expression in cells of donors D4, D5 and D6 at the 1 h and 6 h time
points. Ratios were calculated as log2 values. Positive values indicate upregulation as compared to mock infection/treatments and are represented by
red coloration. Negative values indicate down regulation and are represented by green colors. White indicates no change in gene expression
(log2=0). Each gene has been tested with 5 different stimuli (ZEBOV, VLPVP40-GP, VLPs VLPVP40, LPS, and neutral latex beads), in 3 donors at 2 time
points (1 h and 6 h post infection). This provides a total of 30 different evaluations of changes in expression levels per gene. Blocks of three (1 h or
6 h for 3 donors) or six variables (e.g. VLP) can clearly be seen. (B) Color-coded second-dimensional clustering based on genes with similar changes in
expression levels. Fold-changes in cellular gene expression following exposure to Ebola virions or treatment with VLPVP40-GP after 1 h (C) and 6 h (D)
incubation of human macrophages from donors D4, D5 and D6. Data represent the median values of the fold-changes in log2 of cellular gene
expression of donors D4–6.
doi:10.1371/journal.pntd.0001359.g006
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compared to mock-exposure at 1 h (A) and 6 h (B).
(TIF)
Table S1 Summary of genes identified using threshold
and trend analysis. 88 genes were identified from both
threshold and trend analysis. Genes are grouped according to
their known functions, determined by GeneOntology descriptors
[53]. Many of these genes express proteins involved in apoptosis,
inflammatory and acute immune responses, blood coagulation,
and tissue remodeling.
(DOCX)
Acknowledgments
The authors gratefully acknowledge Fabian de Kok-Mercado for assistance
with figures and Dr. Peter Jahrling for helpful discussions. The content of
this publication does not necessarily reflect the views or policies of the US
Department of Health and Human Services or of the institutions and
companies affiliated with the authors.
Author Contributions
Conceived and designed the experiments: VWJ SK DRB HF. Performed
the experiments: VWJ SK FF HF. Analyzed the data: VWJ SK LKB JK
VD JdSC KF JHK DRB HF. Contributed reagents/materials/analysis
tools: VWJ SK FF LKB JK VD JdSC KF DRB HF. Wrote the paper: VWJ
SK JK JHK HF.
References
1. Feldmann H, Geisbert TW, Jahrling PB, Klenk HD, Netesov SV, et al. (2005)
Filoviridae. In: Fauquet CM, Mayo MA, Maniloff J, Desselberger U, Ball LA,
eds. Virus Taxonomy, VIIIth Report of the ICTV. London: Elsevier. pp
645–653.
2. Johnson KM, Webb PA, Lange JV, Murphy FA (1977) Isolation and partial
characterisation of a new virus causing acute haemorrhagic fever in Zaire.
Lancet 309: 569–571.
3. Kuhn JH (2008) Filoviruses. A compendium of 40 years of epidemiological,
clinical, and laboratory studies. Arch Virol Suppl 20: 13–360.
4. Geisbert TW, Young HA, Jahrling PB, Davis KJ, Larsen T, et al. (2003)
Pathogenesis of Ebola hemorrhagic fever in primate models: evidence that
hemorrhage is not a direct effect of virus-induced cytolysis of endothelial cells.
Am J Pathol 163: 2371–2382.
5. Geisbert TW, Hensley LE, Larsen T, Young HA, Reed DS, et al. (2003)
Pathogenesis of Ebola hemorrhagic fever in cynomolgus macaques: evidence
that dendritic cells are early and sustained targets of infection. Am J Pathol 163:
2347–2370.
6. Villinger F, Rollin PE, Brar SS, Chikkala NF, Winter J, et al. (1999) Markedly
Elevated Levels of Interferon (IFN)-c, IFN-a, Interleukin (IL)-2, IL-10, and
Tumor Necrosis Factor-a Associated with Fatal Ebola Virus Infection. The
Journal of Infectious Diseases - Official Publication of the Infectious Diseases
Society of America (Chicago) 179(suppl. 1): S188–S191.
7. Baize S, Leroy EM, Georges-Courbot MC, Capron M, Lansoud-Soukate J, et al.
(1999) Defective humoral responses and extensive intravascular apoptosis are
associated with fatal outcome in Ebola virus-infected patients. Nat Med 5:
423–426.
8. Leroy EM, Baize S, Volchkov VE, Fisher-Hoch SP, Georges-Courbot MC, et al.
(2000) Human asymptomatic Ebola infection and strong inflammatory response.
Lancet 355: 2210–2215.
9. Baize S, Leroy EM, Georges AJ, Georges-Courbot MC, Capron M, et al. (2002)
Inflammatory responses in Ebola virus-infected patients. Clin Exp Immunol 128:
163–168.
10. Leroy EM, Baize S, Debre P, Lansoud-Soukate J, Mavoungou E (2001) Early
immune responses accompanying human asymptomatic Ebola infections. Clin
Exp Immunol 124: 453–460.
11. Wauquier N, Becquart P, Padilla C, Baize S, Leroy EM (2010) Human fatal
zaire ebola virus infection is associated with an aberrant innate immunity and
with massive lymphocyte apoptosis. PLoS Negl Trop Dis 4.
12. Zaki SR, Shieh WJ, Greer PW, Goldsmith CS, Ferebee T, et al. (1999) A novel
immunohistochemical assay for the detection of Ebola virus in skin: implications
for diagnosis, spread, and surveillance of Ebola hemorrhagic fever. Commission
de Lutte contre les Epidemies a Kikwit. J Infect Dis 179 Suppl 1: S36–47.
13. Geisbert TW, Young HA, Jahrling PB, Davis KJ, Kagan E, et al. (2003)
Mechanisms underlying coagulation abnormalities in ebola hemorrhagic fever:
overexpression of tissue factor in primate monocytes/macrophages is a key
event. J Infect Dis 188: 1618–1629.
14. Schnittler HJ, Feldmann H (1998) Marburg and Ebola hemorrhagic fevers: does
the primary course of infection depend on the accessibility of organ-specific
macrophages? Clin Infect Dis 27: 404–406.
15. Ryabchikova EI, Kolesnikova LV, Luchko SV (1999) An analysis of features of
pathogenesis in two animal models of Ebola virus infection. J Infect Dis 179
Suppl 1: S199–202.
16. Stro ¨her U, West E, Bugany H, Klenk H-D, Schnittler H-J, et al. (2001) Infection
and activation of monocytes by Marburg and Ebola viruses. J Virol 75:
11025–11033.
17. Gibb TR, Norwood DA, Jr., Woollen N, Henchal EA (2002) Viral replication
and host gene expression in alveolar macrophages infected with Ebola virus
(Zaire strain). Clin Diagn Lab Immunol 9: 19–27.
18. Gupta M, Mahanty S, Ahmed R, Rollin PE (2001) Monocyte-derived human
macrophages and peripheral blood mononuclear cells infected with ebola virus
secrete MIP-1alpha and TNF-alpha and inhibit poly-IC-induced IFN-alpha in
vitro. Virology 284: 20–25.
19. Wahl-Jensen V, Kurz SK, Hazelton PR, Schnittler H-J, Stro ¨her U, et al. (2005)
Role of Ebola Virus Secreted Glycoproteins and Virus-Like Particles in
Activation of Human Macrophages. J Virol 79: 2413–2419.
20. Kato-Maeda M, Gao Q, Small PM (2001) Microarray analysis of pathogens and
their interaction with hosts. Cell Microbiol 3: 713–719.
21. Manger ID, Relman DA (2000) How the host ‘sees’ pathogens: global gene
expression responses to infection. Curr Opin Immunol 12: 215–218.
22. Cummings CA, Relman DA (2000) Using DNA microarrays to study host-
microbe interactions. Emerg Infect Dis 6: 513–525.
23. Tan SL, Ganji G, Paeper B, Proll S, Katze MG (2007) Systems biology and the
host response to viral infection. Nature biotechnology 25: 1383–1389.
24. Katze MG, Fornek JL, Palermo RE, Walters KA, Korth MJ (2008) Innate
immune modulation by RNA viruses: emerging insights from functional
genomics. Nature reviews Immunology 8: 644–654.
25. Moe JB, Lambert RD, Lupton HW (1981) Plaque Assay for Ebola virus. J Clin
Microbiol 13: 791–793.
26. Hazelton PR, Coombs KM (1999) The reovirus mutant tsA279 L2 gene is
associated with generation of a spikeless core particle: implications for capsid
assembly. J Virol 73: 2298–2308.
27. Eisen MB, Spellman PT, Brown PO, Botstein D (1998) Cluster analysis and
display of genome-wide expression patterns. Proc Natl Acad Sci U S A 95:
14863–14868.
28. Lynn DJ, Winsor GL, Chan C, Richard N, Laird MR, et al. (2008) InnateDB:
facilitating systems-level analyses of the mammalian innate immune response.
Molecular systems biology 4: 218.
29. Yuen T, Wurmbach E, Pfeffer RL, Ebersole BJ, Sealfon SC (2002) Accuracy and
calibration of commercial oligonucleotide and custom cDNA microarrays.
Nucleic Acids Res 30: e48.
30. Kuhn JH, Radoshitzky SR, Guth AC, Warfield KL, Li W, et al. (2006)
Conserved receptor-binding domains of Lake Victoria marburgvirus and Zaire
ebolavirus bind a common receptor. J Biol Chem 281: 15951–15958.
31. Manicassamy B, Wang J, Jiang H, Rong L (2005) Comprehensive analysis of
ebola virus GP1 in viral entry. J Virol 79: 4793–4805.
32. Bavari S, Bosio CM, Wiegand E, Ruthel G, Will AB, et al. (2002) Lipid raft
microdomains: a gateway for compartmentalized trafficking of Ebola and
Marburg viruses. J Exp Med 195: 593–602.
33. Noda T, Sagara H, Suzuki E, Takada A, Kida H, et al. (2002) Ebola virus VP40
drives the formation of virus-like filamentous particles along with GP. J Virol 76:
4855–4865.
34. Okumura A, Pitha PM, Yoshimura A, Harty RN (2010) Interaction between
Ebola virus glycoprotein and host toll-like receptor 4 leads to induction of
proinflammatory cytokines and SOCS1. Journal of virology 84: 27–33.
35. Basler CF, Mikulasova A, Martinez-Sobrido L, Paragas J, Muhlberger E, et al.
(2003) The Ebola virus VP35 protein inhibits activation of interferon regulatory
factor 3. J Virol 77: 7945–7956.
36. Basler CF, Wang X, Muhlberger E, Volchkov V, Paragas J, et al. (2000) The
Ebola virus VP35 protein functions as a type I IFN antagonist. Proc Natl Acad
Sci U S A 97: 12289–12294.
37. Cardenas WB, Loo YM, Gale M, Jr., Hartman AL, Kimberlin CR, et al. (2006)
Ebola virus VP35 protein binds double-stranded RNA and inhibits alpha/beta
interferon production induced by RIG-I signaling. J Virol 80: 5168–5178.
38. Feng Z, Cerveny M, Yan Z, He B (2007) The VP35 protein of Ebola virus
inhibits the antiviral effect mediated by double-stranded RNA-dependent
protein kinase PKR. J Virol 81: 182–192.
39. Prins KC, Cardenas WB, Basler CF (2009) Ebola virus protein VP35 impairs the
function of interferon regulatory factor-activating kinases IKKepsilon and TBK-
1. J Virol 83: 3069–3077.
40. Reid SP, Leung LW, Hartman AL, Martinez O, Shaw ML, et al. (2006) Ebola
virus VP24 binds karyopherin alpha1 and blocks STAT1 nuclear accumulation.
J Virol 80: 5156–5167.
41. Mateo M, Reid SP, Leung LW, Basler CF, Volchkov VE (2010) Ebolavirus
VP24 binding to karyopherins is required for inhibition of interferon signaling.
J Virol 84: 1169–1175.
EBOV-Induced Changes in Macrophage Gene Expression
www.plosntds.org 15 October 2011 | Volume 5 | Issue 10 | e135942. Haasnoot J, de Vries W, Geutjes EJ, Prins M, de Haan P, et al. (2007) The Ebola
virus VP35 protein is a suppressor of RNA silencing. PLoS Pathog 3: e86.
43. Harris RS, Bishop KN, Sheehy AM, Craig HM, Petersen-Mahrt SK, et al.
(2003) DNA deamination mediates innate immunity to retroviral infection. Cell
113: 803–809.
44. Perron MJ, Stremlau M, Song B, Ulm W, Mulligan RC, et al. (2004)
TRIM5alpha mediates the postentry block to N-tropic murine leukemia viruses
in human cells. Proc Natl Acad Sci U S A 101: 11827–11832.
45. Neil SJ, Zang T, Bieniasz PD (2008) Tetherin inhibits retrovirus release and is
antagonized by HIV-1 Vpu. Nature 451: 425–430.
46. Weidner JM, Jiang D, Pan XB, Chang J, Block TM, et al. (2010) Interferon-
Induced Cell Membrane Proteins, IFITM3 and Tetherin, Inhibit Vesicular
Stomatitis Virus Infection via Distinct Mechanisms. J Virol 84: 12646–12657.
47. Radoshitzky SR, Dong L, Chi X, Clester JC, Retterer C, et al. (2010) Infectious
Lassa virus, but not filoviruses, is restricted by BST-2/tetherin. J Virol 84:
10569–10580.
48. Brass AL, Huang IC, Benita Y, John SP, Krishnan MN, et al. (2009) The IFITM
proteins mediate cellular resistance to influenza A H1N1 virus, West Nile virus,
and dengue virus. Cell 139: 1243–1254.
49. Huang ICea (2011) IFITM proteins restrict cathepsin-dependent entry of
Marburg virus, Ebola virus, and SARS coronavirus. PLoS Pathog;In press.
50. Leroy EM, Kumulungui B, Pourrut X, Rouquet P, Hassanin A, et al. (2005)
Fruit bats as reservoirs of Ebola virus. Nature 438: 575–576.
51. Towner JS, Amman BR, Sealy TK, Carroll SA, Comer JA, et al. (2009) Isolation
of genetically diverse Marburg viruses from Egyptian fruit bats. PLoS Pathog 5:
e1000536.
52. Spurgers KB, Alefantis T, Peyser BD, Ruthel GT, Bergeron AA, et al. (2010)
Identification of Essential Filovirion-associated Host Factors by Serial Proteomic
Analysis and RNAi Screen. Mol Cell Proteomics 9: 2690–2703.
53. Harris MA, Clark J, Ireland A, Lomax J, Ashburner M, et al. (2004) The Gene
Ontology (GO) database and informatics resource. Nucleic Acids Res 32:
D258–261.
EBOV-Induced Changes in Macrophage Gene Expression
www.plosntds.org 16 October 2011 | Volume 5 | Issue 10 | e1359